There is no question that our nation’s health care system requires substantial reform. The status quo of soaring health care costs, struggling families, and health care provider shortages across Maine and the nation is unacceptable. Senator Collins frequently works with her colleagues on both sides of the aisle to address these and other important issues facing our nation such as improved mental health care, drug treatment programs, supporting America’s caregivers, and nutrition programs.

As a native to northern Maine, Senator Collins understands the specific challenges that rural communities face for medical care. Throughout her time in the Senate, Senator Collins has consistently supported programs to expand access to and improve the health care system, particularly for citizens living in rural areas. 

As a freshman legislator, Senator Collins founded the Senate Diabetes Caucus and has since led the effort to more than triple federal funding for diabetes research.

Senators Collins, Shaheen Urge CMS to Provide Coverage for Glucose Monitoring Smartphone Apps

Washington, D.C. – The co-chairs of the Senate and House Diabetes Caucus, U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) and U.S. Representatives Tom Reed (R-NY) and Diana DeGette (D-CO), sent a letter to Seema Verma, Administrator of the Centers for Medicare and Medicaid Services (CMS), urging the agency to review a Medicare policy that prohibits beneficiaries from using smartphone applications in conjunction with their continuous glucose monitors (CGM). 



Legislation to Lower Health Insurance Premiums in Individual Market by up to 40% Proposed for Omnibus Spending Bill

Would also help those who are below 250% of the poverty level who receive government assistance to help them pay for their deductibles and co-pays 

“A self-employed plumber making $60,000 may be paying $20,000 for health insurance. Our proposal could cut up to $8,000 from that insurance bill.”

—Sens. Lamar Alexander and Susan Collins, Congressmen Greg Walden and Ryan Costello


Leading Health Care and Business Groups Urge Congress to Take Action to Lower Health Care Premiums

Leading health care and business groups joined together this morning to call on Congressional Leadership to take urgent action to reduce premiums for millions of Americans and their families.


Dear Leaders McConnell and Schumer, Speaker Ryan, and Leader Pelosi:


Americans need action now.


We came together earlier this month to stress the importance of congressional action to lower healthcare premiums. Time is running out.



Senators Collins, McCaskill, Stabenow Lead Bipartisan Group of Senators in Introducing Legislation to Prohibit “Gag Clauses” That Cause Consumers to Pay Higher Prices for Prescription Drugs

Washington, D.C. — Today, U.S. Senators Susan Collins (R-ME), Claire McCaskill (D-MO), and Debbie Stabenow (D-MI) led a bipartisan group of Senators in introducing two bills to remove barriers that prevent patients from paying the lowest possible price for prescription drugs.  The Patient Right to Know Drug Prices Act and the Know the Lowest Price Act would prohibit health insurers and pharmacy benefit managers from using “pharmacy gag clauses” – an egregious practice that some companies use to conceal prices from patients at the pharmacy.


Government Funding Bill Includes Provisions to Address Doctor Shortages & Train Next Generation of Physicians

Washington, D.C. — Following a bipartisan effort led by Senators Susan Collins (R-ME) and Jon Tester (D-MT), the government funding bill will extend and provide $126.5 million for each of fiscal years 2018 and 2019 for the successful Teaching Health Centers Graduate Medical Education Program, which trains physicians in underserved, community-based settings. 



Following a Longtime Effort from Senators Collins and Shaheen, Medicare May Now Provide Coverage for New Lifesaving Diabetes Therapies

Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), the co-chairs of the Senate Diabetes Caucus, released the following statement after the Centers for Medicare and Medicaid Services (CMS) announced that new technologies used for the delivery of insulin, such as the Omnipod system, may now be covered under Medicare Part D. 


Collins, Klobuchar, Baldwin Press Strongbridge Biopharma for Answers on Dramatic Price Increase for Keveyis Drug that Treats Glaucoma and Rare Genetic Disease

Washington, D.C. - U.S. Senators Susan Collins (R-ME), Amy Klobuchar (D-MN), and Tammy Baldwin (D-WI) have pressed Strongbridge Biopharma for answers on the dramatic price increase for Keveyis, formerly known as Daranide, a drug that treats glaucoma and a type of rare genetic disease known as periodic paralysis, which causes attacks of muscle weakness or loss of muscle movement. After a series of companies bought and sold the right to the decades-old dichlorphenamide, the list price was hiked from $50 to $13,650 for 100 pills in 2015.


Collins, King Join Bipartisan Group of Senators to Urge Congressional Leadership to Commit Resources to Opioid Epidemic

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King joined a bipartisan group of nine senators in a letter to Leaders McConnell (R-Ky.) and Schumer (D-N.Y.) today calling on them to provide states like Maine with the resources they need to tackle the ongoing opioid epidemic. In their letter, the bipartisan group urged Senate leadership to include additional funding dedicated to addressing the public health crisis in the upcoming supplemental and omnibus appropriations legislation.



Senator Collins Joins Bipartisan Group of 24 Senators to Cosponsor Legislation to Stabilize Premiums, Increase Access to Insurance

U.S. Senator Susan Collins, a member of the Senate Health Committee, today joined a group of 24 senators – 12 Republicans and 12 Democrats led by Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) – who support bipartisan legislation to help stabilize premiums and access to insurance in individual health insurance markets.


Senators Collins, Shaheen’s Bipartisan Legislation to Establish National Diabetes Commission Heads to President’s Desk

Washington, D.C. - The National Clinical Care Commission Act recently passed Congress unanimously and will now head to the President’s desk to be signed into law. The bipartisan legislation was authored by U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), co-chairs of the Senate Diabetes Caucus, to establish a national commission of health care experts to advance diabetes care and prevention.


More Than 300 Advocacy Groups Oppose Graham-Cassidy

Washington, D.C. - More than 300 health care advocacy groups, including several representing Mainers, oppose the Graham-Cassidy health care proposal. This astonishing number of advocacy groups representing physicians, patients, insurance providers, and hospitals highlighted a wide range of reasons for their opposition to the proposal, including:



Subscribe to Health Care